CLINICAL_TRIALS trial_result · 2015-12-14

Clinical Trial Update: A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis [Phase 3]

Tanabe's TAU-284 completed a long-term Phase 3 study in pediatric patients with perennial allergic rhinitis; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Tanabe Pharma Corporation | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2015-12-14